Literature DB >> 24164606

Drug development study designs have reached the danger zone.

Kenneth Getz1, Rafael Campo.   

Abstract

Mesh：

Year:  2013        PMID： 24164606     DOI： 10.1586/17512433.2013.841539

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  2 in total

1.  Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.

Authors:  Ana Marušić; Darko Hren; Bernadette Mansi; Neil Lineberry; Ananya Bhattacharya; Maureen Garrity; Juli Clark; Thomas Gesell; Susan Glasser; John Gonzalez; Carolyn Hustad; Mary-Margaret Lannon; LaVerne A Mooney; Teresa Peña
Journal:  BMC Med       Date:  2014-10-24       Impact factor: 8.775

2.  Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.

Authors:  Nerina Vischer; Constanze Pfeiffer; Jennifer Kealy; Christian Burri
Journal:  Glob Health Res Policy       Date:  2017-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.